Perfusion Imaging of Ovarian Masses with Contrast-enhanced Ultrasonography

YANG Fan, YANG Tai-zhu, TIAN Tian, WANG Jing-xin, LUO Hong

Abstract

To determine the perfusion features of ovarian masses and their diagnostic value. Methods Contrast-enhanced ultrasonography (CEUS) of 81 ovarian masses were confirmed by surgical pathology. Time-intensity curves of perfusion were obtained for the interest areas of ovarian mass. CEUS perfusion parameters were estimated, including rise time (RT), time to peak (TTP), peak intensity (PI), time from peak to one half (TTH) and area under the curve (AUC). Repeatability of those parameters was tested. Differences in the perfusion parameters were tested between benign and malignant masses, between tumor and non-tumor masses, between different differentiated and stages of ovarian cancers, between cancers with and without lymph-node metastases, and between primary and metastatic cancers. Receive operating characteristic (ROC) curve analyses were performed to determine the cutoff values of perfusion parameters for discriminating cancer from benign ovarian masses. Results Good intra-observer repeatability was reached in the five perfusion parameter measurements. PI, TTH and AUC increased significantly in ovarian cancer and tumor compared with benign and non-tumor masses (P<0.05). PI, TTH and AUC were effective parameters in diagnosing ovarian cancer. AUC had the highest diagnostic effectiveness, with a sensitivity of 87.3% and a specificity of 80.8% at the cutoff value of 877 dB·s. There were no differences in the parameters between different differentiated and stages of ovarian cancers, between cancers with and without lymph-node metastases, and between the primary and metastatic cancers. Conclusion Malignant ovarian cancer has higher PI, TTH and AUC values in CEUS. AUC has certain value in diagnosing ovarian cancer.

 

Keywords: Ovarian mass, Contrast-enhanced ultrasonography, Time-intensity curve, Cutoff value, Perfusion parameters

 

Full Text:

PDF


References


SONG Y. YANG J, LIU Z, et al. Preoperative evaluation of endometrial carcinoma by contrast- enhanced ultrasonography. BJOG,2009,116(2):294-298,

FARINA R. PENNISI F, ROSA ML, et al. Functional study of the transplanted kidney with power Doppler US and time-intensity curves. Radiol Med.2007,112( 1) ;64-73.

YOSHIDAK, SHIM ADA K, TANAKA A, et al. Quantitative analysis of myocardial contrast enhancement by first-pass 64-multidetector computed tomography in patients with coronary heart disease. Circ J ,2009,73(1); 116-124.

NEMEC U, NEMECSF, NOVOTNY C, elal. Quantitative evaluation of contrast-enhanced ultrasound after intravenous administration of a microbubble contrast agent for differentiation of benign and malignant thyroid nodules: assessment of diagnostic accuracy. Eur Radiol. 2012,22(6): 1357-1365.

GIANG UB, JONES MC, KAULE MJ, et al. Quantitative analysis of spherical microbubble cavity array formation in thermally cured polydimethylsiloxane for use in cell sorting applications. Biomed Microdevices, 2014 ,16( 1):55-67.

QUAIA E. PALUMBO A, ROSSI S, elal. Comparison of visual and quantitative analysis for characterization of insonated liver tumors after microbubble contrast injection. AJR Am J Roentgenol,2012,186(6): 1560-1570.

PARK S, DIANISS, THOMENIUS KE, et al. Quantitative analysis of subharmonic imaging using microbubbles in contrast imaging. In: IEEE International Ultrasonics Symposium,IU. Orlando, FL, USA:IEEE,2011;640-643.

KIYONOS, MARUYAMA H, KOBAYASHI K. et al. Non-invasive diagnosis of portal hypertensive gastropathy; quantitative analysis of microbubble-induced stomach wall enhancement. Ultrasound Med Biol,2016,42(8); 1792-1799.

DU R. LU KV, PETRITSCH C, et al. HIFlalpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell, 2008,13(3): 206-220.

LEE TY, PUR DIE TG, STEWART E. CT imaging of angiogenesis. Q J Nucl Med,2003,47(3); 171-187.

MILES KA, CHARNSANGAVEJ C, LEE FT, et al. Application of CT in the investigation of angiogenesis in oncology. Acad Radiol ,2000,7( 10) ; 840-850.

ORDEN MR. GUDMUNDSSON S, KIRKINEN P. Contrast-enhanced sonography in the examination of benign and malignant adnexal masses. J Ultrasound Med, 2000, 19 (11);783-788.

ORDEN MR. JURVELIN JS, KIRKINEN PP. Kinetics of a US contrast agent in benign and malignant adnexal tumors. Radiology,2003,226(2);405-410.

MARRETH, SAUGET S, GIRAUDEAU B. et al. Contrast-enhanced sonography helps in discrimination of benign from maligant adnexal masses. J Ultrasound Med, 2004.24(12):1629-1639.

FLEISCHER AC. LYSCHIK A. JONES HW. et al. Contrast-enhanced transvaginal sonography of benign versus malignant ovarian masses. J Ultrasound Med, 2008. 27 ( 7 ): 1011-1018.


Refbacks

  • There are currently no refbacks.